-
3-Deazaadenosine Hydrochloride in m6A Research
2026-09-25
3-Deazaadenosine hydrochloride is an S-adenosylhomocysteine hydrolase inhibitor for probing SAHH-dependent methyl metabolism. It can complement genetic studies of the IGF2BP1–m6A–TUBB4B pathway, but it is not a direct or pathway-specific m6A inhibitor.
-
Direct Mouse Genotyping Kit: Workflow and QC
2026-09-25
The Direct Mouse Genotyping Kit supports genomic DNA release and PCR amplification from mouse tissue without conventional DNA purification, helping simplify routine mouse genetic screening. Use it for validated genotyping assays, not as a substitute for assay development or purified DNA workflows when sample quality, sensitivity, or downstream requirements demand them.
-
ML133 HCl: Interpreting Kir2.1 Perturbation
2026-09-24
ML133 HCl is a selective potassium channel inhibitor that can help researchers test how Kir2.1 activity relates to pulmonary vascular cell behavior. This article focuses on experimental interpretation—especially pH-dependent potency, causal inference, and separating channel effects from downstream signaling—not just compound handling.
-
CHK1 Inhibition in Breast Cancer: ER/PR-Dependent Effects
2026-09-24
This study shows that CHK1 inhibition has different effects across breast cancer subtypes defined by oestrogen- and progesterone-receptor status: it enhanced adriamycin sensitivity in receptor-negative models but not in ER+/PR+ models. The findings support subtype-aware testing of CHK1-targeted strategies and distinguish combination treatment effects from single-agent activity.
-
NVP-BGJ398 Phosphate: FGFR Research Workflows
2026-09-23
NVP-BGJ398 phosphate enables biomarker-guided inhibition of FGFR1–3 in cancer-cell, signaling, and skeletal-disease models. This workflow-focused guide connects target validation with practical formulation, assay design, and troubleshooting strategies.
-
3-Deazaadenosine Hydrochloride in m6A Workflows
2026-09-22
Use 3-Deazaadenosine hydrochloride as an upstream perturbation tool to test whether SAHH-dependent methyl metabolism contributes to m6A-linked RNA regulation. Its value is greatest when paired with genetic, RNA-stability, and pathway assays rather than interpreted as a direct IGF2BP1 or TUBB4B inhibitor.
-
Demethyleneberberine in Con A Autoimmune Hepatitis
2026-09-22
The reference study shows that Demethyleneberberine (DMB) protects mice from concanavalin A-induced autoimmune hepatitis by reducing inflammatory signaling, immune-cell infiltration, and oxidative stress. Its integrated pharmacological and molecular readouts position DMB as a promising anti-autoimmune hepatitis agent candidate while also defining important limits for translation beyond this preclinical model.
-
Canagliflozin and Proximal Tubule Mitochondria
2026-09-21
A 2025 study found that canagliflozin improved mitochondrial network structure and bioenergetic performance in proximal tubular cells from hypertensive–diabetic mice, with stronger effects in males than females. The work extends interpretation of SGLT2 inhibition beyond glucose lowering by connecting renal protection with mitochondrial remodeling, while also highlighting the limits of short-term, sex-specific animal data.
-
Demethyleneberberine: NSCLC Assay Workflow
2026-09-21
Build a mechanism-led Demethyleneberberine workflow for NSCLC proliferation, migration, cell-cycle, and senescence studies. The same compound can be extended into macrophage inflammation, colonic epithelial, and autoimmune hepatitis models when solubility, vehicle exposure, and endpoint timing are controlled.
-
Demethyleneberberine: From Pathways to Translation
2026-09-20
A translational framework for using Demethyleneberberine to connect c-Myc/HIF-1α-driven senescence in NSCLC with inflammation-focused assay design and preclinical strategy.
-
Phytol: From RXR Mechanism to Translational Design
2026-09-19
Phytol is more than a catalog small molecule: it is a mechanistically layered probe spanning retinoid X receptor signaling, PPARα regulation, and GABAergic transmission modulation. This thought-leadership guide shows how to design isomer-aware, solvent-controlled validation workflows while using soft-matter assembly research as a disciplined analogy for formulation strategy—not as evidence of direct receptor activity.
-
3-Deazaadenosine hydrochloride: Assay Design
2026-09-19
3-Deazaadenosine hydrochloride can function as a mechanistic probe of SAHH-dependent methyl metabolism in hepatic stellate cell research. This article presents an assay-design framework for separating global methylation effects from the IGF2BP1–TUBB4B–FAK pathway described in liver fibrosis.
-
Phytol Workflows for RXR Assay Optimization
2026-09-18
Build solvent-aware, isomer-conscious workflows for investigating Phytol in retinoid X receptor signaling, PPARα regulation, and GABAergic transmission modulation. A polymer self-assembly study provides a practical framework for separating composition, architecture, and kinetic effects without confusing materials-science analogies with receptor evidence.
-
AI-10-49 Workflow for AML Research
2026-09-18
AI-10-49 enables mechanism-driven studies of CBFβ-SMMHC by linking target engagement, RUNX1 chromatin restoration, and leukemia-cell survival. This practical workflow helps researchers connect acute myeloid leukemia models with MYCN/eIF4G1 biology while separating validated findings from assay-optimization recommendations.
-
Demethyleneberberine in Neurodegenerative Disorders
2026-09-17
The 2022 Molecular Biology Reports review presents Demethyleneberberine (DMB) as a potentially neuroprotective berberine metabolite with antioxidant, anti-inflammatory, and mitochondrial effects. Its main contribution is a mechanistic framework linking NF-κB, MAPK, and AMPK signaling to neurodegenerative disease biology while emphasizing that experimental validation remains necessary.